XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Cash Flows [Abstract]    
Net income (loss): $ (6,057,776) $ 288,124
Adjustments to reconcile net income from operations to net cash provided by operating activities:    
Depreciation and amortization 1,566,141 3,907
Depreciation of right-of-use assets 763,641 215,690
Accounts receivable impairment 2,226,090
Changes in operating assets and liabilities:    
Accounts receivable (9,323,279) (5,398,432)
Inventories 343,395 (6,869,171)
Prepaid expenses and other current assets 56,486 77,987
Accounts payable 13,737,398 (13,320,148)
Contract liabilities (940,014) 471,745
Accrued liabilities and other payables 360,761 323,866
Income tax payable (481,113) 202,759
Net cash (used in)provided by operating activities 2,251,730 (24,003,673)
Cash flows from investing activities:    
Purchase of property, plant and equipment (495,065) (120,948)
Purchase of short-term investment (9,604,418)
Net cash used in investing activities (10,099,483) (120,948)
Cash flows from financing activities:    
Payment made for dividends (3,384,678) (449,026)
Advances from related parties 1,934,855 1,681,723
Repayment of advances from related parties (40,512,691) (1,804,786)
Principal portion of lease payment (634,776) (203,612)
Net cash used in financing activities (42,597,290) (775,701)
Net decrease in cash and cash equivalents (50,445,043) (24,900,322)
Cash and cash equivalents - beginning of period 74,480,651 85,248,997
Cash and cash equivalents - end of period $ 24,035,608 $ 60,348,675